Capella Scientia Development Study
Key facts
- Who runs it
- Alcon Research
- Where
- Salt Lake City, United StatesSee the siteAlso in 3 other countries, 4 sites
- Trial code
- Status
- Recruiting
- People taking part
- 400 people, planned
- Started
- 30 Jul 2025
- Expected to end
- May 2027
- Type of study
- Observational, 4 groups
- Treatments tested
- Unity DX and SMARTCataract DX (SCDX) Biometer
- IOLMaster 700 Biometer
- Argos with Alcon Image Guidance Biometer
- Record updated
- 30 October 2026
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- Able to understand and sign an IRB/IEC approved consent form
- Willing and able to attend study visit(s) as required by the protocol
- Consenting age at the jurisdiction of study site
- Other group-specific, protocol required inclusion criteria may apply
Who cannot take part
- Contraindicated for pupil dilation (e.g., narrow angles, allergies) per investigator's clinical judgment
- Any ocular disease and/or condition that, in the investigator's clinical judgment, may put the subject at significant risk, may compromise study results, or may interfere significantly with the subject's participation in the study
- Women of child-bearing potential
- Unable to fixate due to nystagmus or other eye movement abnormality (e.g., significant strabismus)
- Unclear optical media preventing data capture from all devices in the study
- Other group-specific, protocol required exclusion criteria may apply
This trial is currently available in United States.
Also in 3 other countries, 4 sites
- The Eye Institute of UtahSalt Lake City, United StatesTaking people
About the trial
What the trial wants to find out
This study involves collecting biometry and aberration data using the next generation biometer, Unity DX.
The 4 groups in the trial
- Group 1
Subjects/eyes previously implanted with an Alcon monofocal or multifocal presbyopia correcting IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.
Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer
- Group 2
Subjects/eyes with planned implantation of an Alcon monofocal or monofocal toric IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.
Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer
- Group 3
Subjects/eyes with with prior refractive surgery such as LASIK or PRK and planned implantation of an Alcon monofocal or monofocal toric IOL. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.
Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer
- Group 4
Subjects/eyes with keratoconus, a progressive cornea disorder. Measurements will be taken with Unity DX and SMARTCataract DX (SCDX) Biometer and either the IOLMaster 700 Biometer or the Argos with Alcon Image Guidance Biometer depending on which device is used at site.
Treatment: Unity DX and SMARTCataract DX (SCDX) Biometer, IOLMaster 700 Biometer, and Argos with Alcon Image Guidance Biometer
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Capella Scientia (SCDX) Development Study
- Record updated
- 30 October 2026